Bombesin-like receptor 3
From Wikipedia, the free encyclopedia
Bombesin-like receptor 3
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | BRS3; | |||||||||||||
External IDs | OMIM: 300107 MGI: 1100501 HomoloGene: 1307 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 680 | 12209 | ||||||||||||
Ensembl | ENSG00000102239 | ENSMUSG00000031130 | ||||||||||||
Uniprot | P32247 | O54798 | ||||||||||||
Refseq | NM_001727 (mRNA) NP_001718 (protein) |
NM_009766 (mRNA) NP_033896 (protein) |
||||||||||||
Location | Chr X: 135.4 - 135.4 Mb | Chr X: 53.39 - 53.4 Mb | ||||||||||||
Pubmed search | [1] | [2] |
The bombesin-like receptor 3 (BRS-3) is a G protein-coupled receptor.[1] As no endogenous ligand has been identified for BRS-3, it is classified as an orphan receptor.
Mammalian bombesin-like peptides (see MIM 137260) are widely distributed in the central nervous system as well as in the gastrointestinal tract, where they modulate smooth-muscle contraction, exocrine and endocrine processes, metabolism, and behavior. They bind to G protein-coupled receptors on the cell surface to elicit their effects. Bombesin-like peptide receptors include gastrin-releasing peptide receptor (MIM 305670), neuromedin B receptor (MIM 162341), and bombesin-like receptor-3 (BRS3) (Ohki-Hamazaki et al., 1997).[supplied by OMIM][2]
[edit] References
- ^ Fathi Z, Corjay MH, Shapira H, Wada E, Benya R, Jensen R, Viallet J, Sausville EA, Battey JF (1993). "BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells". J. Biol. Chem. 268 (8): 5979–84. PMID 8383682.
- ^ Entrez Gene: BRS3 bombesin-like receptor 3.
[edit] Further reading
- Gorbulev V, Akhundova A, Grzeschik KH, Fahrenholz F (1994). "Organization and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus.". FEBS Lett. 340 (3): 260–4. PMID 8131855.
- Fathi Z, Corjay MH, Shapira H, et al. (1993). "BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells.". J. Biol. Chem. 268 (8): 5979–84. PMID 8383682.
- Kane MA, Toi-Scott M, Johnson GL, et al. (1996). "Bombesin-like peptide receptors in human bronchial epithelial cells.". Peptides 17 (1): 111–8. PMID 8822519.
- Ohki-Hamazaki H, Watase K, Yamamoto K, et al. (1997). "Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity.". Nature 390 (6656): 165–9. doi: . PMID 9367152.
- Ryan RR, Weber HC, Hou W, et al. (1998). "Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.". J. Biol. Chem. 273 (22): 13613–24. PMID 9593699.
- Liu J, Lao ZJ, Zhang J, et al. (2002). "Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3).". Biochemistry 41 (28): 8954–60. PMID 12102638.
- Ross MT, Grafham DV, Coffey AJ, et al. (2005). "The DNA sequence of the human X chromosome.". Nature 434 (7031): 325–37. doi: . PMID 15772651.
- Hou X, Wei L, Harada A, Tatamoto K (2007). "Activation of bombesin receptor subtype-3 stimulates adhesion of lung cancer cells.". Lung Cancer 54 (2): 143–8. doi: . PMID 16979789.
- Tan YR, Qin XQ, Xiang Y, et al. (2007). "PPARalpha and AP-2alpha regulate bombesin receptor subtype 3 expression in ozone-stressed bronchial epithelial cells.". Biochem. J. 405 (1): 131–7. doi: . PMID 17355223.
[edit] External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain.